Close

Lymphoma

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Lymphoma is a group of blood cancers that originates from cells of the lymph system. As the broad distribution range of lymph system, lymphoma can start almost anywhere through the body. The two main categories of lymphomas are Hodgkin lymphoma (accounts for 10% ) and non-Hodgkin lymphoma (NHL accounts for about 90% ). Although both of these two types can occur at any age, lymphoma is most commonly diagnosed in young people. Hodgkin lymphoma can be classified into many subtypes, however, most cases are usually classic type of abnormal B lymphocyte, called Reed-Sternberg cells. Hodgkin lymphoma are usually treatable. NHL also has different types depending on the white blood cells types they arise from, such as B-cells, T-cells and NK cells. Scientists have identified certain risk factors which may be related to the development of lymphoma, such as age, sex, location, infection Immune deficiency etc. Although there're some common ones, the signs and symptoms of lymphoma vary between different types. Thus the treatment and the out come may depend on the grade and the type of this disease.

In 2008, WHO classified lymphoma into 5 subtypes (NHL are classifed into 4 subtypes):

Mature B cell neoplasms
Mature T cell and natural killer (NK) cell neoplasms
Precursor lymphoid neoplasms
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.